{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:21:00Z","timestamp":1791040860688,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02533-4","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:12:10Z","timestamp":1737357130000},"page":"1293-1302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Delphi consensus on the diagnostic criteria of polycystic ovary syndrome"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-9564","authenticated-orcid":false,"given":"Fabio","family":"Facchinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6734","authenticated-orcid":false,"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6186-0106","authenticated-orcid":false,"given":"Gianluca","family":"Aimaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-8141","authenticated-orcid":false,"given":"Alberto","family":"Ferlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1543-2802","authenticated-orcid":false,"given":"Antonio Simone","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-0297","authenticated-orcid":false,"given":"Paolo","family":"Moghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-1465","authenticated-orcid":false,"given":"Mario","family":"Montanino Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-3181","authenticated-orcid":false,"given":"Vittorio","family":"Unfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-2559","authenticated-orcid":false,"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"2533_CR1","doi-asserted-by":"crossref","unstructured":"Unfer V, Kandaraki E, Pkhaladze L, Roseff S, Vazquez-Levin MH, Lagan\u00e0 AS et al (2024) When one size does not fit all: reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments. Endocr Metabolic Sci. 14:100159","DOI":"10.1016\/j.endmts.2024.100159"},{"issue":"4","key":"2533_CR2","first-page":"e58733","volume":"16","author":"R Choudhari","year":"2024","unstructured":"Choudhari R, Tayade S, Tiwari A, Satone P (2024) Diagnosis, management, and Associated comorbidities of Polycystic Ovary Syndrome: a narrative review. Cureus 16(4):e58733","journal-title":"Cureus"},{"key":"2533_CR3","doi-asserted-by":"crossref","unstructured":"Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 29(2):181\u2013191","DOI":"10.1016\/S0002-9378(15)30642-6"},{"key":"2533_CR4","doi-asserted-by":"crossref","unstructured":"Revised (2003) consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u2013\u20097","DOI":"10.1093\/humrep\/deh098"},{"issue":"3","key":"2533_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L et al (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 110(3):364\u2013379","journal-title":"Fertil Steril"},{"issue":"4","key":"2533_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT et al (2023) Recommendations from the 2023 International evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertil Steril 120(4):767\u2013793","journal-title":"Fertil Steril"},{"issue":"8","key":"2533_CR7","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1111\/aogs.14802","volume":"103","author":"F de Zegher","year":"2024","unstructured":"de Zegher F, Ib\u00e1\u00f1ez L (2024) Leader vs follower in the tango of polycystic ovary syndrome: insulin resistance vs androgen excess. Acta Obstet Gynecol Scand 103(8):1680\u20131681","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2533_CR8","doi-asserted-by":"crossref","unstructured":"Wen X, Wang L, Bai E (2024) Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome. Front Endocrinol. 2024-July-23;15.","DOI":"10.3389\/fendo.2024.1370578"},{"issue":"11","key":"2533_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.tem.2023.08.005","volume":"34","author":"SH Myers","year":"2023","unstructured":"Myers SH, Russo M, Dinicola S, Forte G, Unfer V (2023) Questioning PCOS phenotypes for reclassification and tailored therapy. Trends Endocrinol Metab 34(11):694\u2013703","journal-title":"Trends Endocrinol Metab"},{"key":"2533_CR10","first-page":"482","volume":"469","author":"LS Fish","year":"1996","unstructured":"Fish LS, Busby DM (1996) The delphi method. Res Methods Family Therapy 469:482","journal-title":"Res Methods Family Therapy"},{"issue":"1","key":"2533_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1477-7827-12-89","volume":"12","author":"F Ramezani Tehrani","year":"2014","unstructured":"Ramezani Tehrani F, Rashidi H, Bahri Khomami M, Tohidi M, Azizi F (2014) The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reproductive Biology Endocrinol 12(1):89 2014\/09\/16;","journal-title":"Reproductive Biology Endocrinol"},{"key":"2533_CR12","doi-asserted-by":"crossref","unstructured":"Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F et al (2022) The prevalence of polycystic ovary syndrome, its phenotypes and cardio-metabolic features in a Community Sample of Iranian Population: Tehran lipid and glucose study. Frontiers in Endocrinology. 2022-March-01;13.","DOI":"10.3389\/fendo.2022.825528"},{"issue":"1","key":"2533_CR13","doi-asserted-by":"publisher","first-page":"e3464","DOI":"10.1002\/dmrr.3464","volume":"38","author":"A Krentowska","year":"2022","unstructured":"Krentowska A, Kowalska I (2022) Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome. Diabetes Metab Res Rev 38(1):e3464","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"2533_CR14","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM et al (2013) Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab 98(4):E628\u2013E637","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2533_CR15","doi-asserted-by":"publisher","first-page":"e3414","DOI":"10.1210\/clinem\/dgab380","volume":"106","author":"F Tosi","year":"2021","unstructured":"Tosi F, Villani M, Migazzi M, Faccin G, Garofalo S, Fiers T et al (2021) Insulin-mediated substrate use in women with different phenotypes of PCOS: the role of androgens. J Clin Endocrinol Metab 106(9):e3414\u2013e25","journal-title":"J Clin Endocrinol Metab"},{"key":"2533_CR16","doi-asserted-by":"crossref","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 16(1):9","DOI":"10.1186\/s13048-022-01091-0"},{"issue":"06\/01\/","key":"2533_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","volume":"2020","author":"S Mumusoglu","year":"2020","unstructured":"Mumusoglu S, Yildiz BO (2020) Polycystic ovary syndrome phenotypes and prevalence: Differential impact of diagnostic criteria and clinical versus unselected population. Curr Opin Endocr Metabolic Res 2020(06\/01\/):12:66\u201371","journal-title":"Curr Opin Endocr Metabolic Res"},{"issue":"6","key":"2533_CR18","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00404-024-07408-2","volume":"309","author":"SH Myers","year":"2024","unstructured":"Myers SH, Montanino Oliva M, Nordio M, Unfer V (2024) PCOS phenotype focus: phenotype D under the magnifying glass. Arch Gynecol Obstet 309(6):2307\u20132313","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"2533_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/BF03350782","volume":"21","author":"R Barnes","year":"2014","unstructured":"Barnes R (2014) The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J Endocrinol Investig 21(9):567\u2013579","journal-title":"J Endocrinol Investig"},{"issue":"11","key":"2533_CR20","first-page":"e49146","volume":"15","author":"GM Attia","year":"2023","unstructured":"Attia GM, Alharbi OA, Aljohani RM (2023) The impact of irregular menstruation on Health: a review of the literature. Cureus 15(11):e49146","journal-title":"Cureus"},{"issue":"3","key":"2533_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00404-024-07571-6","volume":"310","author":"SH Myers","year":"2024","unstructured":"Myers SH, Forte G, Unfer V (2024) Has the name PCOS run its course? Arch Gynecol Obstet 310(3):1761\u20131762","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"2533_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/ejendo\/lvae085","volume":"191","author":"S Livadas","year":"2024","unstructured":"Livadas S, Yildiz BO, Mastorakos G, Gambineri A, Pignatelli D, Giorgino F et al (2024) European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group\u2019s 2023 Questionnaire. Eur J Endocrinol 191(2):134\u2013143","journal-title":"Eur J Endocrinol"},{"key":"2533_CR23","doi-asserted-by":"crossref","unstructured":"Bizuneh AD, Joham AE, Teede H, Mousa A, Earnest A, Hawley JM et al (2025) Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Hum Reprod Updat 31(1):48-63","DOI":"10.1093\/humupd\/dmae028"},{"issue":"12","key":"2533_CR24","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/humrep\/dex308","volume":"32","author":"F Tosi","year":"2017","unstructured":"Tosi F, Bonora E, Moghetti P (2017) Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum Reprod 32(12):2515\u20132521","journal-title":"Hum Reprod"},{"key":"2533_CR25","doi-asserted-by":"publisher","first-page":"117955811987404","DOI":"10.1177\/1179558119874042","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S (2019) Obesity and polycystic ovary syndrome: implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Health 13:1179558119874042","journal-title":"Clin Med Insights Reprod Health"},{"key":"2533_CR26","doi-asserted-by":"crossref","unstructured":"Unfer V, Dinicola S, Russo MAPCOS, Paradox (2023) Does Inositol Therapy find a rationale in all the different phenotypes? Int J Mol Sci. 24(7):6213","DOI":"10.3390\/ijms24076213"},{"key":"2533_CR27","doi-asserted-by":"crossref","unstructured":"Brennan L, Teede H, Skouteris H, Linardon J, Hill B, Moran L (2017) Lifestyle and behavioral management of polycystic ovary syndrome. J Women\u2019s Health. 26(8):836\u2013848","DOI":"10.1089\/jwh.2016.5792"},{"issue":"2","key":"2533_CR28","first-page":"604","volume":"102","author":"M Gibson-Helm","year":"2017","unstructured":"Gibson-Helm M, Teede H, Dunaif A, Dokras A (2017) Delayed diagnosis and a lack of Information Associated with Dissatisfaction in Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102(2):604\u2013612","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2533_CR29","first-page":"e41748","volume":"15","author":"R Bodepudi","year":"2023","unstructured":"Bodepudi R, Seher S, Khan SA, Emmanuel S, Shantha Kumar V, Nerella R et al (2023) Myoinositol Versus Metformin in the treatment of polycystic ovarian syndrome: a systematic review. Cureus 15(7):e41748","journal-title":"Cureus"},{"issue":"6","key":"2533_CR30","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s11845-023-03388-5","volume":"192","author":"K Fatima","year":"2023","unstructured":"Fatima K, Jamil Z, Faheem S, Adnan A, Javaid SS, Naeem H et al (2023) Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis. Ir J Med Sci 192(6):2801\u20132808","journal-title":"Ir J Med Sci"},{"issue":"9","key":"2533_CR31","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s40618-024-02363-w","volume":"47","author":"C Moretti","year":"2024","unstructured":"Moretti C, Bonomi M, Dionese P, Federici S, Fulghesu AM, Giannelli J et al (2024) Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women\u2019s endocrinology. J Endocrinol Invest 47(9):2111\u20132141","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02533-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02533-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02533-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:50:39Z","timestamp":1751536239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02533-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2533"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02533-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"V.U is an employee of Lo.Li Pharma s.r.l, all other authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}